Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention

Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention

The COVID-19 infection caused by the new SARS-CoV-2 virus has been linked to a broad spectrum of symptoms, from a mild cough to life-threatening pneumonia. As we learn more about this unusual COVID-19 epidemic, new issues are emerging and being reported daily. Mucormycosis, also known as zygomycosis...

Full description

Bibliographic Details
Main Authors: Syed Mohammed Basheeruddin Asdaq, Arya Rajan, Aswin Damodaran, Shivali R. Kamath, Krishnanjana S. Nair, Subin Mary Zachariah, Ram Kumar Sahu, Santosh Fattepur, Nagaraja Sreeharsha, Anroop Nair, Shery Jacob, Hussain A. Albahrani, Eman H. Alkhaldi, Yahya Mohzari, Ahmed A. Alrashed, Mohd. Imran
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Antibiotics
Subjects:
COVID-19
mucormycosis
nanotechnology
antifungal
diabetes
diagnosis
Online Access:https://www.mdpi.com/2079-6382/10/11/1308

Internet

https://www.mdpi.com/2079-6382/10/11/1308

Similar Items